Express News | Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
Express News | Aclarion Launches Second Clinical Utility and Economic (Clue) Trial Site With First Surgeon in New Jersey
Express News | Aclarion Launches the Clinical Utility and Economic (Clue) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans